Overdose deaths tied to antianxiety drugs like Xanax continue to rise – Science News

Support nonprofit journalism.
SERENITY PILL  Benzodiazepines, such as Valium and Xanax, are widely prescribed to treat anxiety and insomnia. Also highly addictive, the drugs are involved in more and more overdose deaths. 
Dean812/Flickr (CC BY 2.0)
By
January 17, 2019 at 9:00 am
As public health officials tackle opioid addiction and overdoses, another class of prescription drugs has been contributing to a growing number of deaths across the United States.
Benzodiazepines, such as Valium and Xanax, are commonly prescribed for anxiety and insomnia. The drugs are also highly addictive and can be fatal, especially when combined with alcohol or opioids. In the latest sign of the drug’s impact, the number of overdose deaths involving “benzos” rose from 0.54 per 100,000 in 1999 to 5.02 per 100,000 in 2017 among women aged 30 to 64, researchers report January 11 in the Morbidity and Mortality Weekly Report. That’s a spike of 830 percent, surpassed only by increases seen in overdose deaths involving synthetic opioids or heroin.
Headlines and summaries of the latest Science News articles, delivered to your inbox
Thank you for signing up!
There was a problem signing you up.
Overall, there were 10,684 overdose deaths involving benzodiazepines in the United States in 2016, according to the National Institute on Drug Abuse. In 1999, the total was 1,135.
Benzodiazepines have a sedating effect, and are particularly dangerous when used with other drugs that slow breathing, such as opioids and alcohol. In combination, the substances can “cause people to fall asleep and essentially never wake up again,” says Anna Lembke, an addiction psychiatrist at Stanford University School of Medicine. Benzos and opioids are often prescribed together, and opioids contribute to 75 percent of overdose deaths involving benzos.
The rising number of deaths involving benzos hasn’t stopped the flow of prescriptions. The number of U.S. adults who filled a prescription for benzos rose from 8.1 million in 1996 to 13.5 million in 2013, a jump of 67 percent, a study in the American Journal of Public Health in 2016 found. The quantity of benzos acquired more than tripled over the same time.
Number of U.S. overdose deaths involving benzodiazepines, 1999–2016
Benzodiazepines work by enhancing the activity of a chemical messenger in the brain that has a calming effect. The drugs help to distribute this neutrotransmitter, called gamma-aminobutyric acid, more widely in the brain. The drugs also work quickly, bringing fast relief.
Benzos are relatively safe for intermittent use over a few weeks. But with daily, long-term use the brain adapts to the drugs. As a result, they become less effective at relieving symptoms, and a person “needs more and more to get the same effect,” Lembke says. “It’s really easy to get people on these drugs, and hard to get them off again.”
Many of those who take the drugs aren’t using them properly, according to a study published online in Psychiatric Services in 2018. Of 30.6 million adults who reported using benzodiazepines, 5.3 million acknowledged misuse, such as taking benzos without a prescription or in a way not approved by a doctor.
National efforts to combat the opioid crisis should also target benzodiazepines, to reduce overprescribing and to educate doctors and patients about the drugs’ risks, Lembke and colleagues wrote in a February 2018 commentary in the New England Journal of Medicine.
Safer treatments for anxiety and insomnia are available, including antidepressants called selective serotonin reuptake inhibitors and therapies to change behaviors and learn coping strategies. Lembke says that benzodiazepines are more appropriate for short duration, low-dose treatment in severe circumstances, such as for seizures. That’s “how the evidence supports their use.”
Questions or comments on this article? E-mail us at feedback@sciencenews.org
A version of this article appears in the February 16, 2019 issue of Science News.
J. VanHouten et al. Drug overdose deaths among women aged 30–64 years — United States, 1999–2017. Morbidity and Mortality Weekly Report. Vol. 68, January 11, 2019, p. 1. doi:10.15585/mmwr.mm6801a1.
D. Maust, L. Lin and F. Blow. Benzodiazepine use and misuse among adults in the United States. Psychiatric Services. Published online December 17, 2018.  doi:10.1176/appi.ps.201800321.
A. Lembke, J. Papac and K. Humphreys. Our other prescription drug problem. New England Journal of Medicine. Vol. 378, February 22, 2018, p. 693. doi:10.1056/NEJMp1715050.
M. Bachhuber et al. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. American Journal of Public Health. Vol. 106, April 2016, p. 686. doi:10.2015/AJPH.2016.303061.
Aimee Cunningham is the biomedical writer. She has a master’s degree in science journalism from New York University.
Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our mission remains the same: to empower people to evaluate the news and the world around them. It is published by the Society for Science, a nonprofit 501(c)(3) membership organization dedicated to public engagement in scientific research and education.
© Society for Science & the Public 2000–2022. All rights reserved.
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.
Not a subscriber?
Become one now.
Here’s why you should subscribe anyway.
To celebrate our centennial, we have made our entire archive available for free. But quality journalism comes at a price. Support the next century of science journalism. Subscribe to Science News for as little as $2.99 a month.

source

Leave a Comment

Your email address will not be published.

Shopping Cart